Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin J Maldonato

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Scientific Reports|March 2, 2021
Human METTL7B is an alkyl thiol methyltransferase that metabolizes hydrogen sulfide and captoprilBenjamin J Maldonato, Drake A Russell, Rheem A Totah
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 3, 2023
METTL7A (TMT1A) and METTL7B (TMT1B) Are Responsible for Alkyl <i>S</i>-Thiol Methyl Transferase Activity in LiverDrake A Russell, Marvin K Chau, Yuanyuan Shi, et al.
Drug Metabolism Reviews|July 26, 2024
Enzyme-mediated drug-drug interactions: a review of <i>in vivo</i> and <i>in vitro</i> methodologies, regulatory guidance, and translation to the clinicJaydeep Yadav, Benjamin J Maldonato, Joseph M Roesner, et al.
Drug Metabolism Reviews|July 5, 2024
Transporter-mediated drug-drug interactions: regulatory guidelines, <i>in vitro</i> and <i>in vivo</i> methodologies and translation, special populations, and the blood-brain barrierLaura E Russell, Jaydeep Yadav, Benjamin J Maldonato, et al.
Drug Metabolism Reviews|August 18, 2024
Insights into pharmacogenetics, drug-gene interactions, and drug-drug-gene interactionsLaura E Russell, Katrina G Claw, Kaja M Aagaard, et al.
Drug Metabolism Reviews|July 25, 2022
Epigenetics in drug disposition & drug therapy: symposium report of the 24<sup>th</sup> North American meeting of the International Society for the Study of Xenobiotics (ISSX)Benjamin J Maldonato, Ana G Vergara, Jaydeep Yadav, et al.
Cancer Discovery|June 22, 2026
Selective Inhibition of KRASG13C Reveals an Increased Dependence on Wild-Type RAS Isoforms in Codon 13 RAS-Mutant CancersKyle J Seamon, Yongxian Zhuang, Yu Chi Yang, et al.
Cancer Discovery|October 6, 2025
Correction: Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven CancersJingjing Jiang, Lingyan Jiang, Benjamin J Maldonato, et al.
Cancer Discovery|April 9, 2024
Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven CancersJingjing Jiang, Lingyan Jiang, Benjamin J Maldonato, et al.
Cancer Discovery|February 11, 2026
Abrogation of Oncogenic RAS Signaling by a RAS(ON) Inhibitor Doublet Primes Immune-refractory KRAS G12C-mutant NSCLC for Immune Checkpoint BlockadeXing Wei, Cristina Blaj, M Ali Al-Radhawi, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Scientific Reports|March 2, 2021
Human METTL7B is an alkyl thiol methyltransferase that metabolizes hydrogen sulfide and captoprilBenjamin J Maldonato, Drake A Russell, Rheem A Totah
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 3, 2023
METTL7A (TMT1A) and METTL7B (TMT1B) Are Responsible for Alkyl <i>S</i>-Thiol Methyl Transferase Activity in LiverDrake A Russell, Marvin K Chau, Yuanyuan Shi, et al.
Drug Metabolism Reviews|July 26, 2024
Enzyme-mediated drug-drug interactions: a review of <i>in vivo</i> and <i>in vitro</i> methodologies, regulatory guidance, and translation to the clinicJaydeep Yadav, Benjamin J Maldonato, Joseph M Roesner, et al.
Drug Metabolism Reviews|July 5, 2024
Transporter-mediated drug-drug interactions: regulatory guidelines, <i>in vitro</i> and <i>in vivo</i> methodologies and translation, special populations, and the blood-brain barrierLaura E Russell, Jaydeep Yadav, Benjamin J Maldonato, et al.
Drug Metabolism Reviews|August 18, 2024
Insights into pharmacogenetics, drug-gene interactions, and drug-drug-gene interactionsLaura E Russell, Katrina G Claw, Kaja M Aagaard, et al.
Drug Metabolism Reviews|July 25, 2022
Epigenetics in drug disposition & drug therapy: symposium report of the 24<sup>th</sup> North American meeting of the International Society for the Study of Xenobiotics (ISSX)Benjamin J Maldonato, Ana G Vergara, Jaydeep Yadav, et al.
Cancer Discovery|June 22, 2026
Selective Inhibition of KRASG13C Reveals an Increased Dependence on Wild-Type RAS Isoforms in Codon 13 RAS-Mutant CancersKyle J Seamon, Yongxian Zhuang, Yu Chi Yang, et al.
Cancer Discovery|October 6, 2025
Correction: Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven CancersJingjing Jiang, Lingyan Jiang, Benjamin J Maldonato, et al.
Cancer Discovery|April 9, 2024
Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven CancersJingjing Jiang, Lingyan Jiang, Benjamin J Maldonato, et al.
Cancer Discovery|February 11, 2026
Abrogation of Oncogenic RAS Signaling by a RAS(ON) Inhibitor Doublet Primes Immune-refractory KRAS G12C-mutant NSCLC for Immune Checkpoint BlockadeXing Wei, Cristina Blaj, M Ali Al-Radhawi, et al.
Pageof 1